Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Vincent LaPointe"'
Autor:
Matthew Chan, Robert Olson, Vincent Lapointe, Jeremy Hamm, Francois Bachand, Caroline Holloway, Christina Parsons, Peter Lim
Publikováno v:
Current Oncology, Vol 29, Iss 5, Pp 3306-3317 (2022)
There are limited patient-reported outcome (PRO) data tracking changes in toxicity in patients actively undergoing radiotherapy. Between 2015–2019, acute toxicity was prospectively measured in 698 patients undergoing a 5-week course of pelvic radio
Externí odkaz:
https://doaj.org/article/0bb69b627a4646478d95dda2bbf0a51a
Autor:
Robert A. Olson, Vincent LaPointe, Alex Benny, Matthew Chan, Shilo Lefresne, Michael McKenzie
Publikováno v:
Current Oncology, Vol 29, Iss 3, Pp 2073-2080 (2022)
We assessed whether advanced RT techniques were associated with differences in patient-reported outcomes (PROs). Patients with bone metastases who completed the brief pain inventory (BPI) before and after RT were identified, and RT technique was cate
Externí odkaz:
https://doaj.org/article/8b76b05b3f68439192c3dc7d7657b46c
Autor:
Daegan Sit, MD, Michelle Bale, MD, Vincent Lapointe, PhD, Robert Olson, MD, MSc, Fred Hsu, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 8, Pp 100371- (2022)
Introduction: After palliative radiotherapy for bone metastases from NSCLC, up to 30% of patients may derive no symptomatic benefit, and there are a lack of biological predictors for this. The purpose was to investigate whether EGFR and ALK genetic r
Externí odkaz:
https://doaj.org/article/d975a3b69c9f4b829eacb0b9d99e9de7
Publikováno v:
The Journal of Organic Chemistry. 88:6557-6564
Autor:
Justin Oh, W. James Morris, Ingrid Spadinger, Scott Tyldesley, Mira Keyes, Ross Halperin, Juanita Crook, Vincent Lapointe, Tom Pickles
Publikováno v:
Brachytherapy. 21:605-616
To evaluate the outcomes of unfavorable intermediate-risk (UIR) and high-risk (HR) prostate cancer patients treated with combined external beam radiation therapy (EBRT) and low-dose-rate prostate brachytherapy (LDR-PB).A population-based cohort of 56
Autor:
Jonathan Olivier, Weiyu Li, Daan Nieboer, Jozien Helleman, Monique Roobol, Vincent Gnanapragasam, Mark Frydenberg, Mikio Sugimoto, Peter Carroll, Todd M. Morgan, Riccardo Valdagni, Jose Rubio-Briones, Grégoire Robert, Phillip Stricker, Andrew Hayen, Ivo Schoots, Masoom Haider, Caroline M. Moore, Brian Denton, Arnauld Villers, Bruce Trock, Behfar Ehdaie, Christopher Filson, Christopher Logothetis, Todd Morgan, Laurence Klotz, Tom Pickles, Eric Hyndman, Caroline M Moore, Mieke Van Hemelrijck, Prokar Dasgupta, Chris Bangma, Axel Semjonow, Antti Rannikko, Antoinette Perry, Jonas Hugosson, Anders Bjartell, Lukas Hefermehl, Lee Lui Shiong, Byung Ha Chung, Theo van der Kwast, Tim Hulsen, Wim van der Linden, Boris Ruwe, Peter van Hooft, Ewout Steyerberg, Paul Boutros, Wei Guo, Nicole Benfante, Janet Cowan, Dattatraya Patil, Lauren Park, Stephanie Ferrante, Alexandre Mamedov, Vincent LaPointe, Trafford Crump, Vasilis Stavrinides, Jenna Kimberly-Duffell, Aida Santaolalla, Tiziana Rancati, Helén Ahlgren, Juanma Mascarós, Annica Löfgren, Kurt Lehmann, Catherine Han Lin, Thomas Cusick, Hiromi Hirama, Kwang Suk Lee, Guido Jenster, Anssi Auvinen, Kees van Bochove, Michelle Kouspou, Kellie Paich
Publikováno v:
European Urology Open Science
European Urology Open Science, 35, 59-67. Elsevier
European Urology Open Science, 35, 59-67. Elsevier
Take Home Messages Among men with low- or intermediate-risk prostate cancer who choose active surveillance, those with suspicious magnetic resonance imaging (MRI) at the time of inclusion in active surveillance are more likely to show switch to treat
Publikováno v:
Organic Letters. 23:8606-8611
Substituted polyhydroquinolines are ubiquitous skeletal cores found in drugs and bioactive natural products. As a new route to access this motif, we successfully developed a one-pot cyclization cascade with high chemocontrol and diastereoselectivity.
Autor:
Arthur Gouhier, Justine Dumoulin-Gagnon, Vincent Lapointe-Roberge, Aurelio Balsalobre, Jacques Drouin
SummaryPioneer transcription factors direct cell differentiation by deploying new enhancer repertoires through their unique ability to target and initiate remodelling of closed chromatin. The initial steps of their action remain undefined although pi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ddae4468fb730f95c9c121221074c2b
https://doi.org/10.1101/2022.11.16.516735
https://doi.org/10.1101/2022.11.16.516735
Autor:
Eric Tran, Sonya Lam, Sarah Hamilton, Jonn Wu, Eric Berthelet, Matthew Chan, Sheena Sibug, Paul Willinsky, Vincent Lapointe, Jeremy Hamm, Robert Olson
Publikováno v:
Radiotherapy and Oncology. 174:S38-S39
Autor:
Sebastiaan Remmers, Jozien Helleman, Daan Nieboer, Bruce Trock, Matthew E. Hyndman, Caroline M. Moore, Vincent Gnanapragasam, Lui Shiong Lee, Oussama Elhage, Laurence Klotz, Peter Carroll, Tom Pickles, Anders Bjartell, Grégoire Robert, Mark Frydenberg, Mikio Sugimoto, Behfar Ehdaie, Todd M. Morgan, Jose Rubio-Briones, Axel Semjonow, Chris H. Bangma, Monique J. Roobol, Christopher Filson, Christopher Logothetis, Todd Morgan, Eric Hyndman, Caroline Moore, Mieke Van Hemelrijck, Prokar Dasgupta, Chris Bangma, Monique Roobol, Arnauld Villers, Antti Rannikko, Riccardo Valdagni, Antoinette Perry, Jonas Hugosson, Lukas Hefermehl, Lee Lui Shiong, Phillip Stricker, Byung Ha Chung, Theo van der Kwast, Wim van der Linden, Tim Hulsen, Boris Ruwe, null Peter van Hooft, Ewout Steyerberg, Kerri Beckmann, Brian Denton, Andrew Hayen, Paul Boutros, Wei Guo, Nicole Benfante, Janet Cowan, Dattatraya Patil, Lauren Park, Stephanie Ferrante, Alexandre Mamedov, Vincent LaPointe, Trafford Crump, Vasilis Stavrinides, Jenna Kimberly-Duffell, Aida Santaolalla, Jonathan Olivier, Tiziana Rancati, Helén Ahlgren, Juanma Mascarós, Annica Löfgren, Kurt Lehmann, Catherine Han Lin, Thomas Cusick, Hiromi Hirama, Kwang Suk Lee, Guido Jenster, Anssi Auvinen, Masoom Haider, Kees van Bochove, Michelle Kouspou, Kellie Paich
Publikováno v:
European Urology Open Science, 41, 126-133. Elsevier
BackgroundActive surveillance (AS) is a management option for men diagnosed with low-risk prostate cancer. Opinions differ on whether it is safe to include young men (≤60 yr) or men with intermediate-risk disease.ObjectiveTo assess whether reasons